Impaired M. tuberculosis antigen-specific IFN-γ response without IL-17 enhancement in patients with severe cavitary pulmonary tuberculosis

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Fan, Lin ^a   Xiao, Heping ^a   Mai, Guangliang ^a   Su, Bo ^a   Ernst, Joel ^b   Hu, Zhongyi ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; INTERLEUKIN 17; PHYTOHEMAGGLUTININ; TUBERCULIN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CD3+ CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INCUBATION TIME; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; T LYMPHOCYTE; BIOSYNTHESIS; BLOOD; CD4+ T LYMPHOCYTE; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); TH17 CELL; TUBERCULOSIS, PULMONARY;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; LUNG; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TH17 CELLS; TUBERCULOSIS, PULMONARY;

EID: 84959266827     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127087     Document Type: Article

References (34)

1. Eurosurveillance editorial team.WHO publishes Global tuberculosis report 2013. Euro Surveill. 2013;18. pii: 20615.
2. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010; 375:1920-1937. doi: 10.1016/S0140-6736(10)60359-5 PMID: 20488517
3. Geldmacher C, Zumla A, Hoelscher M. Interaction between HIV and Mycobacterium tuberculosis: HIV- 1-induced CD4 T-cell depletion and the development of active tuberculosis. Curr Opin HIV AIDS. 2012; 7:268-275. doi: 10.1097/COH.0b013e3283524e32 PMID: 22495739
4. Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med. 2010; 207:2869-2881. doi: 10.1084/jem.20100090 PMID: 21115690
5. Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clinical microbiology reviews. 2011; 24: 351-376. doi: 10.1128/CMR.00042-10 PMID: 21482729
6. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009; 23: 1717-1725. doi: 10.1097/QAD.0b013e32832d3b6d PMID: 19461502
7. Dorhoi A, Reece ST, Kaufmann SH. For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection. Immunological reviews. 2011; 240: 235-251. doi: 10.1111/j.1600-065X.2010.00994.x PMID: 21349097
8. Saunders BM, Britton WJ. Life and death in the granuloma: immunopathology of tuberculosis. Immunology and cell biology. 2007; 85: 103-111. PMID: 17213830
9. Mukadi Y, Perriëns JH, St Louis ME, Brown C, Prignot J, Willame JC, et al. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet. 1993; 342:143-146. PMID: 8101257
10. Mazzarella G, Bianco A, Perna F, D'Auria D, Grella E, Moscariello E, et al. T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis. Clin Exp Immunol. 2003; 132:283-288. PMID: 12699418
11. Barry S, Breen R, Lipman M, Johnson M, Janossy G. Tuberculosis (Edinb). 2009; 89:48-53. doi: 10.1016/j.tube.2008.07.002 PMID: 18799355
12. Desvignes L, Ernst JD. Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity. 2009; 31:974-985. doi: 10.1016/j.immuni.2009.10. 007 PMID: 20064452
13. Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, et al. Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature. 2010; 467:967-971. doi: 10.1038/nature09447 PMID: 20962846
14. Wozniak TM, Saunders BM, Ryan AA, Britton WJ. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis Infection in the absence of gamma infection. Infection and Immunity. 2010; 78:4187-4194. doi: 10.1128/IAI.01392-09 PMID: 20679438
15. Umemura M, Yahagi A, Hamada S, Begum MD, Watanabe H, Kawakami K, et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette- Guerin infection. J Immunol. 2007; 178:3786-3796. PMID: 17339477
16. Okamoto Yoshida Y, Umemura M, Yahagi A, O'Brien RL, Ikuta K, Kishihara K, et al. Essential role of IL- 17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol. 2010; 184:4414-4422. doi: 10.4049/jimmunol.0903332 PMID: 20212094
17. Cruz A, Fraga AG, Fountain JJ, Rangel-Moreno J, Torrado E, Saraiva M, et al. Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med.2010; 207:1609-1616. doi: 10.1084/jem.20100265 PMID: 20624887
18. Green AM, Difazio R, Flynn JL. IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J Immunol. 2013; 190:270-277. doi: 10.4049/jimmunol.1200061 PMID: 23233724
19. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol. 1999; 162:5407-5416. PMID: 10228018
20. Lyadova IV, Vordermeier HM, Eruslanov EB, Khaidukov SV, Apt AS, Hewinson RG. Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs. Clin Exp Immunol, 2001; 126:274-279. PMID: 11703371
21. Fan L, Xiao HP, Hu ZY, Ernst JD. Variation of Mycobacterium tuberculosis antigen-specific IFN-γ and IL-17 responses in healthy tuberculin skin test (TST)-positive human subjects. PLoS One. 2012; 7: e42716. doi: 10.1371/journal.pone.0042716 PMID: 22880090
22. Kübler A, Luna B, Larsson C, Ammerman NC, Andrade BB, Orandle M, et al. Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation. J Pathol. 2015; 235:431-444. doi: 10.1002/path.4432 PMID: 25186281
23. Peng MY, Wang ZH, Yao CY, Jiang LN, Jin QL, Wang J, et al. Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis.Cell Mol Immunol. 2008; 5:203-208. doi: 10.1038/cmi.2008.25 PMID: 18582402
24. Jurado JO, Pasquinelli V, Alvarez IB, Peña D, Rovetta AI, Tateosian NL, et al. IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. J Leukoc Biol. 2012; 91:991-1002. doi: 10.1189/jlb.1211619 PMID: 22416258
25. Nunnari G, Pinzone MR, Vancheri C, Palermo F, Cacopardo B. Interferon-γ and interleukin-17 production from PPD-stimulated PBMCss of patients with pulmonary tuberculosis. Clin Invest Med. 2013; 36: E64-71. PMID: 23544607
26. Rodríguez-Güell E, Agustí G, Corominas M, Luquin M, Julián E. Impaired gamma interferon response to Mycobacterium vaccae antigens in patients with cavitary pulmonary tuberculosis. Clin Vaccine Immunol. 2008; 15:1485-1488. doi: 10.1128/CVI.00131-08 PMID: 18596204
27. Wu HP, Hua CC, Chuang DY. Decreased in vitro interferon-gamma production in patients with cavitary tuberculosis on chest radiography. Respir Med. 2007; 101:48-52. PMID: 16753289
28. Kaplan G, Post FA, Moreira AL, Wainwright H, Kreiswirth BN, Tanverdi M, et al. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun. 2003; 71:7099-7108. PMID: 14638800
29. Ulrichs T, Kosmiadi GA, Jörg S, Pradl L, Titukhina M, Mishenko V, et al. Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma. J Infect Dis. 2005; 192:89-97. PMID: 15942898
30. Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat Immunol. 2010; 11:751-758. doi: 10.1038/ni. 1904 PMID: 20622882
31. Singh A, Mohan A, Dey AB, Mitra DK. Inhibiting the Programmed Death 1 Pathway Rescues Mycobacterium tuberculosis-Specific Interferon γ-Producing T Cells From Apoptosis in Patients with Pulmonary Tuberculosis. J Infect Dis. 2013; 208:603-615. doi: 10.1093/infdis/jit206 PMID: 23661793
32. Di Carlo P, Casuccio A, Romano A, Spicola D, Titone L, Caccamo N, et al. Lymphocyte apoptosis in children with central nervous system tuberculosis: a case control study. BMC Pediatr. 2011; 11:108. doi: 10.1186/1471-2431-11-108 PMID: 22111973
33. Condos R, Rom WN, Liu YM, Schluger NW. Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med. 1998; 157(3 Pt 1):729-735. PMID: 9517583
34. Nandi B, Behar SM. Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection. J Exp Med. 2011; 208:2251-2262. doi: 10.1084/jem.20110919 PMID: 21967766